Sepsis Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Global Sepsis Market is Segmented by Technology (Molecular Diagnostics, Microbiology, Immunoassay, and Other Technologies), Product (Instruments, Assays and Reagents, and Other Products), Diagnostic Method (Conventional Diagnostics and Automated Diagnostics), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Other Pathogens), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market size and forecasts are provided in terms of value (in USD million) for the above segments.

Sepsis Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Sepsis Diagnosis Industry Overview

The sepsis diagnostics market is moderately consolidated owing to the presence of a few key players. The market is expected to drive due to the products launched by the key players in the market and the rise in research initiatives on sepsis diagnostics by the key players. Some of the market players are Abbott, Becton, Dickinson, and Company, bioMérieux SA, Bruker Corporation, F. Hoffmann-LA Roche Ltd, and Immunexpress Inc., among others.

Sepsis Diagnosis Market Leaders

  1. Abbott

  2. Diasorin

  3. Becton, Dickinson, and Company

  4. bioMérieux SA

  5. F. Hoffmann-LA Roche Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Sepsis Diagnostics Market Concentration